This venture capital firm was founded in the mid-2000s and manages approximately $100 million in assets across multiple funds. The firm makes equity investments ranging from several hundred thousand dollars to several million dollars, with additional capital reserved for follow-on rounds. The firm invests in companies located throughout North America and Europe and plans to make several new investments over the next year. The firm invests in both early-stage companies and later-stage commercial growth opportunities.
The firm focuses on companies developing medical devices, diagnostics, and healthcare IT products, with an emphasis on capital-efficient technologies that can reach the market quickly and reduce the cost of delivering quality healthcare. The firm is open to a broad range of subsectors and indications within medical technology, with particular interest in technologies related to cardiovascular health and neurological applications.
The firm seeks companies with skilled and experienced management teams. The firm generally looks to take board seats in portfolio companies after investment and plays an active role in supporting company growth and strategic decisions.
If you are interested in more information about this investor and other investors tracked by LSN, please email salescore@lifesciencenation.com.
Next Phase Newsletter 